FDA NDC Directory · JSON-LD · Markdown

Acamprosate Calcium

NDC 50268-028 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA219904
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsACAMPROSATE CALCIUM (333 mg/1)
Marketing started20261026
Package count1

External sources

Source: openFDA. Public-domain (CC0).